Literature DB >> 23361279

Immunohistochemical correlation of epidermal growth factor receptor and c-erbB-2 with histopathologic grading of mucoepidermoid carcinoma.

Monir Moradzadeh Khiavi1, Sepideh Vosoughhosseini, Shirin Saravani, Monireh Halimi.   

Abstract

OBJECTIVE: Mucoepidermoid carcinoma is the most common salivary gland malignancy with highly variable biologic potential that correlates with the histopathologic grade of the tumor. Therefore, identification of the histopathologic grade of the mucoepidermoid carcinoma is very important in the treatment and determination of the final prognosis. The present study was performed to survey immunohistochemically Epidermal Growth Factor ReceptorEGFR and c-erbB-2 expression in different grades of mucoepidermoid carcinoma.
MATERIALS AND METHODS: This retrospective study included 46 formalin-fixed, paraffin-embedded blocks of mucoepidermoid carcinoma. Based on histopathologic parameters, samples were classified into three grades. Then new sections were made and stained by immunohistochemistry (IHC) method for EGFR and c-erbB-2. Finally, EGFR and c-erbB-2 expression and their correlation with histopathologic grading were statistically analyzed by ANOVA. Nineteen samples of normal salivary gland tissue were also chosen as control group.
RESULTS: The means of EGFR and c-erbB-2 were 71%, 71%, respectively. Statistically significant correlation was found between EGFR expression and histopathologic grading of mucoepidermoid carcinoma of salivary glands (P < 0.001). There was no statistically significant correlation between histopathologic grading of salivary gland mucoepidermoid carcinoma and c-erbB-2 expression (P = 0.60).
CONCLUSION: There is a parallelism between an increase in EGFR expression and increase in the histopathologic grading of salivary gland mucoepidermoid carcinoma. Therefore, the biologic behavior of salivary gland mucoepidermoid carcinoma can be determined by EGFR expression and it is a useful technique for determination of tumor grades and probably their prognosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23361279     DOI: 10.4103/0973-1482.106550

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  5 in total

1.  The Role of Human Epidermal Growth Factor Receptor 2 (HER2/neu) in Mucoepidermoid Carcinomas.

Authors:  Shirin Saravani
Journal:  J Clin Diagn Res       Date:  2016-07-01

2.  Tagging staphylococcal enterotoxin B (SEB) with TGFaL3 for breast cancer therapy.

Authors:  Forough Yousefi; Seyed Davar Siadat; Alireza Azizi Saraji; Saeed Hesaraki; Mohammad Mehdi Aslani; Seyed Fazlollah Mousavi; Abbas Ali Imani Fooladi
Journal:  Tumour Biol       Date:  2015-11-11

3.  Assessing the prognostic significance of MUC4β in mucoepidermoid carcinoma of the salivary glands: An immunohistochemical study.

Authors:  Poonam R Sawant; Anita Spadigam; Anita Dhupar; Shaheen Syed; Karla Carvalho
Journal:  Heliyon       Date:  2019-11-14

4.  PCP4/PEP19 and HER2 Are Novel Prognostic Markers in Mucoepidermoid Carcinoma of the Salivary Gland.

Authors:  Takuya Yoshimura; Shotaro Higashi; Sohsuke Yamada; Hirotsugu Noguchi; Mitsuharu Nomoto; Hajime Suzuki; Takayuki Ishida; Hirotaka Takayama; Yuka Hirano; Masaru Yamashita; Akihide Tanimoto; Norifumi Nakamura
Journal:  Cancers (Basel)       Date:  2021-12-23       Impact factor: 6.639

5.  Prognostic and clinical implications of c-erbB-2 expression in patients with oral cancer: A meta-analysis.

Authors:  Ying Meng; Peng Yang; Lili Ma
Journal:  Medicine (Baltimore)       Date:  2020-06-05       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.